Discover
OTLK
Outlook Therapeutics, Inc.
0.64
1 x 0.64
1 x 0.66
bid
ask
-
0.00
0.70%
12:32 PM
timesize
| Ytd | -59.47% | |
| 1y | -24.75% |
0.63
day range
0.66
0.16
52 week range
2.54
| Open | 0.63 | Prev Close | 0.64 | Low | 0.63 | High | 0.66 | Mkt Cap | 155.43M |
| Vol | 4.13M | Avg Vol | 18.67M | EPS | -0.70 | P/E | N/A | Forward P/E | -0.55 |
| Beta | 0.82 | Short Ratio | 1.26 | Inst. Own | 35.63% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 1.20 | 200-d Avg | 0.89 | 1yr Est | 24.80 |
| Income Statement | |||
| Total Revenue | 8.70K | ||
| Revenues (USD) | 8.70K | ||
| Cost of Revenue | 16.97K | ||
| Gross Profit | -8.26K | ||
| Operating Expenses | 10.80M | ||
| Research and Development Expense | 3.25M | ||
| Selling, General and Administrative Expense | 7.55M | ||
| Operating Income | -10.81M | ||
| Interest Expense | -7.00 | ||
| Net Income | -20.32M | ||
| Net Income Common Stock | -20.32M | ||
| Net Income Common Stock (USD) | -20.32M | ||
| Consolidated Income | -20.32M | ||
| Earnings per Basic Share | -0.15 | ||
| Earnings per Basic Share (USD) | -0.15 | ||
| Earnings per Diluted Share | -0.15 | ||
| Earning Before Interest & Taxes (EBIT) | -20.32M | ||
| Earning Before Interest & Taxes (USD) | -20.32M | ||
| Weighted Average Shares | 136.74M | ||
| Weighted Average Shares Diluted | 136.74M | ||
| Balance Sheet | |||
| Cash and Equivalents | 11.24M | ||
| Cash and Equivalents (USD) | 11.24M | ||
| Investments | 2.53M | ||
| Investments Non-Current | 2.53M | ||
| Trade and Non-Trade Receivables | 1.64M | ||
| Current Assets | 23.17M | ||
| Property, Plant & Equipment Net | 185.18K | ||
| Total Assets | 26.18M | ||
| Debt Current | 18.29M | ||
| Total Debt | 18.43M | ||
| Current Liabilities | 28.68M | ||
| Debt Non-Current | 140.13K | ||
| Total Liabilities | 36.58M | ||
| Accumulated Retained Earnings (Deficit) | -653.54M | ||
| Shareholders Equity | -10.39M | ||
| Shareholders Equity (USD) | -10.39M | ||
| Assets Non-Current | 3.02M | ||
| Total Debt (USD) | 18.43M | ||
| Inventory | 5.04M | ||
| Liabilities Non-Current | 7.90M | ||
| Trade and Non-Trade Payables | 6.81M | ||
| Tax Liabilities | 302.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 13.79K | ||
| Net Cash Flow from Financing | 26.60M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.49M | ||
| Issuance (Purchase) of Equity Shares | 29.51M | ||
| Issuance (Repayment) of Debt Securities | -977.61K | ||
| Net Cash Flow from Operations | -21.01M | ||
| Share Based Compensation | 791.67K | ||